SCHEMBL9904241

SCHEMBL9904241

Cn1c(N)c(NC(=O)C#C[Si](C)(C)C)c(=O)n(C)c1=O

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.34
HTT P42858 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
RXFP1 Q9HBX9 5/20 0.33
TDP1 Q9NUW8 1/20 0.33
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9943417 0.78 EPHX2 (0.35) ALDH1A1LMNAKDM4EKMT2AMEN1
SCHEMBL6887802 0.75 ALDH1A1 (0.52) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL17786248 0.71 ALDH1A1 (0.52) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL25229553 0.68 ALDH1A1 (0.63) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL9904076 0.68 ADORA2B (0.37) ALDH1A1KDM4EGLAKMT2AMEN1
SCHEMBL19969556 0.65 ALDH1A1 (0.46) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL7409608 0.65 HTT (0.62) ALDH1A1LMNAKDM4EKMT2AMEN1
SCHEMBL27269701 0.63 ALDH1A1 (0.47) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL21766227 0.62 ALDH1A1 (0.38) ALDH1A1LMNAKDM4EGLAKMT2A
SCHEMBL21750588 0.62 ALDH1A1 (0.43) ALDH1A1LMNAKDM4EGLAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed